KR880011098A - 4-페닐피페리딘 화합물, 이의 제조방법 및 용도 - Google Patents

4-페닐피페리딘 화합물, 이의 제조방법 및 용도 Download PDF

Info

Publication number
KR880011098A
KR880011098A KR1019880003338A KR880003338A KR880011098A KR 880011098 A KR880011098 A KR 880011098A KR 1019880003338 A KR1019880003338 A KR 1019880003338A KR 880003338 A KR880003338 A KR 880003338A KR 880011098 A KR880011098 A KR 880011098A
Authority
KR
South Korea
Prior art keywords
compound
formula
alkyl
phenylpiperidine
give
Prior art date
Application number
KR1019880003338A
Other languages
English (en)
Inventor
웨트젠 프랑크
Original Assignee
죄르젠 부스 라센
에이/에스 페로산
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 죄르젠 부스 라센, 에이/에스 페로산 filed Critical 죄르젠 부스 라센
Publication of KR880011098A publication Critical patent/KR880011098A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음

Description

4-페닐피페리딘 화합물, 이의 제조방법 및 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (9)

  1. 하기 일반식 (Ⅰ)의 4-페닐피페리딘 화합물.
    상기 식에서, R1은 수소, (C1-6-알콕시아릴)알킬, 디페닐메톡시-C1-6-알킬, C1-8알킬, C4-10-사이클로알킬알킬, 페녹시-C1-8-알킬 또는 C1-6-알콕시-C1-6알킬이고 R은또는 CH=NOR'이고 R'는 C1-6-알킬, C3-7-사이클로알킬, C1-6-알콕시-C1-6-알킬, 아릴-C0-6-알킬(이는 하나이상의 할로겐 및 C1-5-알콕시로 임의 치환될 수 있다), 티에틸 또는 C4-7-사이클로알킬알킬이다.
  2. (a)일반식 (Ⅱ)의 화합물의 반응성 유도체를 일반식 (Ⅲ)의 화합물과 반응시켜 일반식 (Ⅰ)의 화합물을 수득하거나, (b)일반식 (Ⅳ)의 화합물을 일반식 (Ⅴ)의 화합물과 반응시켜 일반식 (Ⅵ)의 화합물을 생성시킨 후 생성된 화합물을 하이드록실아민 또는 다른 아미노화제와 반응시켜 일반식 (Ⅰ)의 화합물을 수득하거나, (c)일반식 (Ⅶ)의 화합물을 일반식 NH2-O-R'의 화합물과 반응시켜 일반식 (Ⅰ)의 화합물을 수득하거나, (d)일반식 (Ⅷ)의 화합물을 탈알킬화제와 반응시켜 R'이 수소인 일반식 (Ⅰ)의 화합물을 수득하거나, (e)일반식 (Ⅸ)의 화합물을 알킬화제와 반응시켜 일반식 (Ⅰ)의 화합물을 수득함을 특징으로 하여, 제1항에 따른 화합물을 제조하는 방법.
    상기 식에서, R, R1및 R'는 전술한 바와 같으나, 단, 일반식 (Ⅷ)에서 R1은 수소가 아니다.
  3. 제1항에 있어서, 1-메틸-4-(3-페닐-1,2,4-옥사디아졸-5-일)-4-페닐피페리딘인 화합물.
  4. 제1항에 있어서, 4-(3-사이클로프로필-1,2,4-옥사디아졸-5-일)-4-페닐피페리딘인 화합물.
  5. 제1항에 있어서, 4-메톡시이미노메틸-1-메틸-4-페닐피페리딘인 화합물.
  6. 제1항에 있어서, 4-(3-사이클로프로필-1,2,4-옥사디아졸-5-일)-1-(2-에톡시에틸)-4-페닐피페리딘인 화합물.
  7. 통증을 완화시키기에 유효한 양의 제1항에 따른 화합물을 약학적으로 허용되는 담체 또는 희석제와 함께 함유하는 통증 치료용 약학적 조성물.
  8. 제7항에 있어서, 1 내지 100mg의 활성화합물을 함유하는 경구투여용 단위용량형태인 조성물.
  9. 통증을 완화시키기에 유효한 양의 제1항에 따른 화합물을 이를 필요로 하는 대상에게 투여함을 특징으로 하여, 통증을 치료하는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880003338A 1987-03-31 1988-03-28 4-페닐피페리딘 화합물, 이의 제조방법 및 용도 KR880011098A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK162087A DK162087D0 (da) 1987-03-31 1987-03-31 Piperidinforbindelser, deres fremstilling og anvendelse
DK1620/87 1987-03-31

Publications (1)

Publication Number Publication Date
KR880011098A true KR880011098A (ko) 1988-10-26

Family

ID=8106610

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880003338A KR880011098A (ko) 1987-03-31 1988-03-28 4-페닐피페리딘 화합물, 이의 제조방법 및 용도

Country Status (12)

Country Link
US (1) US4845095A (ko)
EP (1) EP0285032A1 (ko)
JP (1) JPS63258456A (ko)
KR (1) KR880011098A (ko)
AU (1) AU1379488A (ko)
DK (1) DK162087D0 (ko)
FI (1) FI881410A (ko)
IL (1) IL85612A0 (ko)
NO (1) NO881388L (ko)
PH (1) PH24620A (ko)
PT (1) PT87031B (ko)
ZA (1) ZA881799B (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE170174T1 (de) * 1994-01-13 1998-09-15 Merck Sharp & Dohme Gem-bissubstituierte azazyclische tachykinin- antagonisten
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
TW200403058A (en) * 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
US7202259B2 (en) * 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
GB0510142D0 (en) * 2005-05-18 2005-06-22 Addex Pharmaceuticals Sa Novel compounds A1
US11976050B1 (en) 2023-10-11 2024-05-07 King Faisal University N′-(2-(5-(4-chlorophenyl)-1,3,4-oxadiazol-2-ylthio)acetoxy)-1-naphthimidamide as an antimicrobial compound

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016170A (en) * 1975-07-28 1977-04-05 Sandoz, Inc. Oxadiazolyl benzamides

Also Published As

Publication number Publication date
ZA881799B (en) 1988-09-05
AU1379488A (en) 1988-09-29
DK162087D0 (da) 1987-03-31
NO881388L (no) 1988-10-03
FI881410A0 (fi) 1988-03-24
IL85612A0 (en) 1988-08-31
US4845095A (en) 1989-07-04
FI881410A (fi) 1988-10-01
JPS63258456A (ja) 1988-10-25
NO881388D0 (no) 1988-03-29
PT87031A (pt) 1988-04-01
PT87031B (pt) 1992-06-30
EP0285032A1 (en) 1988-10-05
PH24620A (en) 1990-08-17

Similar Documents

Publication Publication Date Title
KR890002060A (ko) 옥사졸리디논 화합물
KR910011891A (ko) 펩티드 화합물, 이의 제조방법 및 이를 함유하는 약학적 조성물
KR880006193A (ko) 피페리딘 화합물 및 그의 제조 및 용도
EP0368388A3 (en) 3-Piperidinyl-1,2-benzisoxazoles
KR880011199A (ko) 신규 펩타이드 화합물, 그의 제조방법 및 그를 함유하는 약학적 조성물
KR890003731A (ko) 인돌 유도체
HK1017274A1 (en) Process for the preparation of pharmaceutical composition containing azasteroid compounds for the treatment of prostatic hypertrophy
KR860006452A (ko) 피페리딘 화합물의 제조 방법
KR910011895A (ko) 약제
KR880003958A (ko) 신규 세펨화합물 및 그의 제조방법
CA2123232A1 (fr) Compositions pharmaceutiques a base d'ebastine ou de ses analogues
KR880011133A (ko) 비스포스폰산 유도체 및 이들을 함유하는 약제
KR880011098A (ko) 4-페닐피페리딘 화합물, 이의 제조방법 및 용도
KR910002835A (ko) 인돌 유도체
KR880001677A (ko) β-락탐 화합물, 그의 제조 방법, 이를 함유하는 세균 감염성 질병 치료용 약제 및 그의 합성을 위한 중간체
KR960017663A (ko) 결합 수용체 길항물질
KR850007427A (ko) 항균 화합물의 제조방법
KR910016691A (ko) 신규한 치환된-아민 화합물 및 그의 제조방법
KR910021400A (ko) 옥사졸리디논
KR930006003A (ko) 이미다졸릴메틸-피리딘류 화합물
KR910000652A (ko) (1,2,3,4-테트라하이드로-9-아크리딘이미노) 사이클로헥산 카복실산 및 관련 화합물, 이들의 제조방법 및 약제로서의 용도
DE3572814D1 (en) 1, 3-benzoxathiole derivatives, their use and their preparation
KR920004402A (ko) 신규 퀴놀린 카르복실산 유도체, 상기 화합물 함유 항균제 및 상기 화합물 제조 방법
NO173278C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive 5-androsten-17-on-derivater
GB2358398B (en) Steroid compounds, a method for preparation thereof, pharmaceutical compositions containing the same and use thereof

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid